Raafat F Alhakeem
Overview
Explore the profile of Raafat F Alhakeem including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
726
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Al-Abdely H, Midgley C, Alkhamis A, Abedi G, Lu X, Binder A, et al.
Emerg Infect Dis
. 2019 Mar;
25(4):753-766.
PMID: 30882305
Middle East respiratory syndrome coronavirus (MERS-CoV) shedding and antibody responses are not fully understood, particularly in relation to underlying medical conditions, clinical manifestations, and mortality. We enrolled MERS-CoV-positive patients at...
2.
Alanazi K, Killerby M, Biggs H, Abedi G, Jokhdar H, Alsharef A, et al.
Infect Control Hosp Epidemiol
. 2019 Jan;
40(1):79-88.
PMID: 30595141
Objective: To investigate a Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak event involving multiple healthcare facilities in Riyadh, Saudi Arabia; to characterize transmission; and to explore infection control implications. Design:...
3.
Al-Abdely H, Midgley C, Alkhamis A, Abedi G, Tamin A, Binder A, et al.
Open Forum Infect Dis
. 2018 Oct;
5(6):ofy111.
PMID: 30294617
Middle East respiratory syndrome coronavirus (MERS-CoV) is associated with a wide range of clinical presentations, from asymptomatic or mildly ill to severe respiratory illness including death. We describe isolation of...
4.
Assiri A, Biggs H, Abedi G, Lu X, Saeed A, Abdalla O, et al.
Open Forum Infect Dis
. 2016 Oct;
3(3):ofw165.
PMID: 27704019
During July-August 2015, the number of cases of Middle East respiratory syndrome (MERS) reported from Saudi Arabia increased dramatically. We reviewed the 143 confirmed cases from this period and classified...
5.
Alhakeem R, Midgley C, Assiri A, Alessa M, Al Hawaj H, Saeed A, et al.
Emerg Infect Dis
. 2016 Sep;
22(11):2020-2022.
PMID: 27606432
No abstract available.
6.
Assiri A, Midgley C, Abedi G, Saeed A, Almasri M, Lu X, et al.
J Infect Dis
. 2016 Jun;
214(5):712-21.
PMID: 27302191
Background: Middle East respiratory syndrome coronavirus (MERS-CoV) causes severe respiratory illness in humans. Fundamental questions about circulating viruses and transmission routes remain. Methods: We assessed routinely collected epidemiologic data for...
7.
El Hassan I, Sahly A, H AlZahrani M, Alhakeem R, Alhelal M, Alhogail A, et al.
Malar J
. 2015 Nov;
14:444.
PMID: 26552387
Background: The draft Global Technical Strategy for malaria aims to eliminate malaria from at least 10 countries by 2020. Yemen and Saudi Arabia remain the last two countries on the...
8.
Muller M, Meyer B, Corman V, Al-Masri M, Turkestani A, Ritz D, et al.
Lancet Infect Dis
. 2015 May;
15(6):629.
PMID: 26008827
No abstract available.
9.
Muller M, Meyer B, Corman V, Al-Masri M, Turkestani A, Ritz D, et al.
Lancet Infect Dis
. 2015 Apr;
15(5):559-64.
PMID: 25863564
Background: Scientific evidence suggests that dromedary camels are the intermediary host for the Middle East respiratory syndrome coronavirus (MERS-CoV). However, the actual number of infections in people who have had...
10.
Coleman M, Al-Zahrani M, Coleman M, Hemingway J, Omar A, Stanton M, et al.
PLoS One
. 2014 Sep;
9(9):e105980.
PMID: 25250619
Significant headway has been made in the global fight against malaria in the past decade and as more countries enter the elimination phase, attention is now focused on identifying effective...